検索結果

Overseas Activities | SENJU Pharmaceutical

Eye health and pharmaceutical development have no borders. We engage in international activities with a view to the future of pharmaceuticals, transcending national and corporate boundaries. As we ent

General Announcement: November 1, 2023 Senju Pharmaceutical Co., Ltd. Launch of Distribution of the OptiLight M22 IPL Model Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. S

Mytear EYETECT ALPITATTO | OTC Products, etc. | Products | SENJU Pharmaceutical

This medicine is recommended for people who have continuing allergy symptoms with inflammation. Category 2 OTC medicines Mytear® EYETECT® ALPITATTO Works on unpleasant eye itching due to pollens and o

Overseas Activities | SENJU Pharmaceutical

Eye health and pharmaceutical development have no borders. We engage in international activities with a view to the future of pharmaceuticals, transcending national and corporate boundaries. As we ent

Quality Policies | About Senju | SENJU Pharmaceutical

We will set the following "Quality Policies" and continue to be a "Good Company" by encouraging cooperation among all employees and providing high-quality products for "realiz